FDA Orders Important Safety Labeling Changes for Addyi Regarding Alcohol Consumption

April 11, 2019 -- The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise important safety information that women and their...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials